Trial Profile
A Phase II Placebo Controlled, Multicenter Study to Investigate the Safety and Efficacy of ATH008 Cream in Patients With Palmar-Plantar Erythrodysesthesia Syndrome (PPES) Secondary to Capecitabine Therapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2016
Price :
$35
*
At a glance
- Drugs Allopurinol (Primary)
- Indications Erythrodysaesthesia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors AdvanCell
- 08 May 2014 New trial record